Aytu Biopharma, Inc. AYTU
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 26.31M | 26.72M | 30.03M | 32.63M | 30.95M |
| Total Receivables | 22.78M | 24.49M | 30.92M | 33.23M | 31.16M |
| Inventory | 6.86M | 7.46M | 8.66M | 10.10M | 11.43M |
| Prepaid Expenses | 5.81M | 8.66M | 6.64M | 5.15M | 5.64M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 61.76M | 67.33M | 76.24M | 81.11M | 79.18M |
|
|
|||||
| Total Current Assets | 61.76M | 67.33M | 76.24M | 81.11M | 79.18M |
| Net Property, Plant & Equipment | 1.24M | 1.32M | 1.44M | 1.51M | 1.59M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 41.40M | 42.49M | 43.58M | 41.43M | 42.20M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 601.00K | 556.00K | 738.00K | 939.00K | 1.20M |
| Total Assets | 105.01M | 111.69M | 122.00M | 124.99M | 124.18M |
|
|
|||||
| Total Accounts Payable | 11.28M | 13.21M | 14.26M | 12.34M | 10.60M |
| Total Accrued Expenses | 14.18M | 13.43M | 16.61M | 16.25M | 15.26M |
| Short-term Debt | 6.07M | 10.41M | 9.08M | 14.87M | 9.06M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.08M | 2.06M | 2.06M | 2.06M | 1.99M |
| Total Finance Division Other Current Liabilities | 21.04M | 20.86M | 23.57M | 20.47M | 26.15M |
| Total Other Current Liabilities | 21.04M | 20.86M | 23.57M | 20.47M | 26.15M |
| Total Current Liabilities | 54.66M | 59.97M | 65.56M | 65.99M | 63.06M |
|
|
|||||
| Total Current Liabilities | 54.66M | 59.97M | 65.56M | 65.99M | 63.06M |
| Long-Term Debt | 9.10M | 9.55M | 10.00M | 10.45M | 10.90M |
| Short-term Debt | 6.07M | 10.41M | 9.08M | 14.87M | 9.06M |
| Capital Leases | 853.00K | 919.00K | 973.00K | 1.02M | 985.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.12M | 6.11M | 31.27M | 24.35M | 30.27M |
| Total Liabilities | 69.73M | 76.55M | 107.80M | 101.82M | 105.21M |
|
|
|||||
| Common Stock & APIC | 383.06M | 382.92M | 356.36M | 354.74M | 352.50M |
| Retained Earnings | -347.79M | -347.77M | -342.15M | -331.57M | -333.54M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 35.27M | 35.14M | 14.20M | 23.17M | 18.97M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 35.27M | 35.14M | 14.20M | 23.17M | 18.97M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 35.27M | 35.14M | 14.20M | 23.17M | 18.97M |
|
|
|||||